Dolly the Sheep Creators Secure New Medical Patent

Send Email

The Rosilin Institute, which stunned the world when they cloned Dolly the Sheep, have secured additional cloning patents, as announced in Earth Times (December 11, 2007). This further strengthens their position in this field and has broad agriculture and medical implications. The new patents (U.S. Patent Nos. 7,304,204 and 7,307,198) cover methods of using differentiated cells to clone ungulate animals, fetuses, and embryos.

 

These patents join a portfolio of patents owned by the Rosilin Institute for cloning using "foundational somatic cell nuclear transfer (SCNT)," which is managed and licensed by Start Licensing, Inc. Other patents in Rosilin’s portfolio include U.S. Patent No. 7,232,938 for a cloning process that uses "fusion or microinjection of a quiescent ungulent donor cell," a method that has been used to clone a farm animals, rodents, and cats and dogs.

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.medicaldevicepatentattorneys.com/2007/12/dolly-the-sheep-creators-secure-new-medical-patent/trackback/
Send To A Friend Use this form to send this entry to a friend via email.